A phase II trial of Xeloda and oxaliplatin (XELOX) neo-adjuvant chemotherapy followed by surgery for advanced gastric cancer patients with para-aortic lymph node metastasis-Reference-Cited by-同舟云学术

A phase II trial of Xeloda and oxaliplatin (XELOX) neo-adjuvant chemotherapy followed by surgery for advanced gastric cancer patients with para-aortic lymph node metastasis

Published:2014-04-21 Issue:6 Volume:73 Page:1155-1161
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Wang Yan,Yu Yi-yi,Li Wei,Feng Yi,Hou Jun,Ji Yuan,Sun Yi-hong,Shen Kun-tang,Shen Zhen-bin,Qin Xin-yu,Liu Tian-shu

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/article/10.1007/s00280-014-2449-1/fulltext.html

Reference23 articles.

1. Forman D, Burley VJ (2006) Gastric cancer: global pattern of the disease and an overview of environmental risk factors. Best Pract Res Clin Gastroenterol 20(4):633–639

2. Baba M, Hokita S, Natsugoe S et al (2000) Paraaortic lymphadenectomy in patients with advanced carcinoma of the upper third of the stomach. Hepatogastroenterology 47(33):893–896

3. Japanese Gastric Cancer Association (2011) Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer 14(2):101–112

4. Edge SB, Compton CC (2010) The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 17(6):1471

5. Sasako M, Sano T, Yamamoto S et al (2008) D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer. N Engl J Med 359(5):453–462

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. First-line camrelizumab (a PD-1 inhibitor) plus apatinib (an VEGFR-2 inhibitor) and chemotherapy for advanced gastric cancer (SPACE): a phase 1 study;Signal Transduction and Targeted Therapy;2024-03-25

2. Prognostic factors of conversion surgery for stage IV gastric cancer: A multi‐institutional retrospective analysis;Annals of Gastroenterological Surgery;2024-01-28

3. The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2023;Cancer Communications;2023-12-31

4. The Clinical Implication of Conversion Surgery in Patients with Stage IV Gastric Cancer Who Received Systemic Chemotherapy;Biomedicines;2023-11-20

5. A meta‐analysis of the effect of laparoscopic gastric resection on the surgical site wound infection in patients with advanced gastric cancer;International Wound Journal;2023-07-26